A Radnor biopharma firm saw its stock price skyrocket after the company posted positive late-stage clinical trial results for ...

Mineralys’ shares got a more than 50% boost Monday morning as new data showed its hypertension drug reduced blood pressure in ...

Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease (CKD), obstructive sleep apnea ...

Medically reviewed by Mary Choy, PharmD It can be surprising to learn that a medication you’re taking for one condition may ...

BioCity Biopharma’s selective endothelin receptor type A (ETA) antagonist has reduced excess proteins in the urine of ...

Learn how failing kidneys cause dangerous fluid buildup, blood cell reduction, heart-threatening electrolyte imbalances, and ...

The emerging role of aldosterone in hypertension and cardiovascular diseases has prompted a renewal of interest in therapeutic approaches designed to interfere with the action of this ...

The Furoscix 80 mg/10 ml subcutaneous injection is intended for oedema in adult CKD patients, including those with nephrotic ...

Acute kidney injury (AKI) and vitamin D deficiency have a bi-directional relationship. Patients with sepsis AKI might be helped by vitamin D supplementation.

Addison’s disease is a rare condition in which the adrenal glands do not produce enough of the hormones cortisol and ...